The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer

Francesco Crea1,2, Erik Venalainen1, Xinpei Ci1,3

  • 1Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver, BC, Canada.

Epigenomics
|April 21, 2016
PubMed

Insights

Neuroendocrine prostate cancer (NEPC) arises from adenocarcinoma cells. Epigenetic factors, including long noncoding RNAs like MIAT, drive NEPC initiation and progression, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Neuroendocrine prostate cancer (NEPC) is the most lethal form of prostate cancer.
  • NEPC is hypothesized to arise from the transdifferentiation of androgen receptor (AR)-positive adenocarcinoma cells.
  • The epigenetic/noncoding interactome (ENI) has been implicated in cancer cell plasticity, leading to metastatic and drug-resistant disease.

Purpose of the Study:

  • To discuss the role of ENI components, such as Polycomb genes and microRNAs (miRNAs), in NEPC initiation and progression.
  • To explore the largely uninvestigated role of long noncoding RNAs (lncRNAs) within the ENI in NEPC.
  • To present preliminary evidence for the lncRNA MIAT as a potential player in NEPC.

Main Methods:

  • Review of existing evidence on ENI components in cancer plasticity and NEPC.
  • Analysis of preliminary data on MIAT expression in NEPC.
  • Investigation of potential interactions between MIAT and Polycomb genes.

Main Results:

  • Specific ENI components, including Polycomb genes and miRNAs, are crucial for NEPC development.
  • The lncRNA MIAT is found to be selectively upregulated in NEPC.
  • Preliminary findings suggest MIAT may interact with Polycomb genes, implicating lncRNAs in NEPC pathogenesis.

Conclusions:

  • Long noncoding RNAs, exemplified by MIAT, are integral to the ENI and play a significant role in NEPC.
  • MIAT and other lncRNAs represent promising novel biomarkers for NEPC detection and prognosis.
  • Targeting lncRNAs offers a potential new therapeutic strategy for combating lethal NEPC.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.1K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
14.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K